Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 2/20 | 0.36 |
| ▸ | NR2C2 | P49116 | 1/20 | 0.35 |
| ▸ | TAB1 | Q15750 | 1/20 | 0.35 |
| ▸ | KDM6B | O15054 | 1/20 | 0.32 |
| ▸ | KDM5C | P41229 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14805495 | 1.00 | MMP3 (0.36) | MMP3NR2C2TAB1KDM6BKDM5C | |
| SCHEMBL817541 | 0.88 | TSHR (0.38) | HTTTSHRALDH1A1LMNA | |
| SCHEMBL889195 | 0.84 | MMP3 (0.33) | MMP3NR2C2TAB1KDM6BKDM5C | |
| SCHEMBL17875663 | 0.81 | MEN1 (0.31) | — | |
| SCHEMBL13374202 | 0.78 | MMP3 (0.36) | MMP3NR2C2TAB1KDM6BKDM5C | |
| SCHEMBL889177 | 0.72 | TSHR (0.37) | HTTTSHRALDH1A1LMNA | |
| SCHEMBL16773690 | 0.70 | MMP3 (0.33) | MMP3KDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL13020728 | 0.68 | — | — | |
| SCHEMBL24759247 | 0.67 | HTT (0.41) | MMP3KDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL20320692 | 0.67 | HTT (0.39) | MMP3KDM6BKDM5CEGLN1PHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110065822-A1 | POROUS RESIN BEAD AND METHOD FOR PRODUCING NUCLEIC ACID USING THE SAME | NITTO DENKO CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065822-A1 | POROUS RESIN BEAD AND METHOD FOR PRODUCING NUCLEIC ACID USING THE SAME | PCNA, PARN, PHAX | MMP3 3476/4885NR2C2 3085/4885TAB1 2280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.